The interaction between programmed cell death-1 (PD-1), expressed on activated T lymphocytes, and programmed cell death-ligand 1 (PD-L1), expressed on antigen-presenting cells and tumour cells, has a major role in suppression of the anti-tumour immune response1. Here, PDCD1 is linked to neoplasm.